Preclinical Pharmacology of GAR-936, a Novel Glycylcycline Antibacterial Agent
- 1 September 2000
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 20 (9 Part 2) , 219S-223S
- https://doi.org/10.1592/phco.20.14.219s.35046
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)Antimicrobial Agents and Chemotherapy, 1999
- Tetracyclines: antibiotic action, uptake, and resistance mechanismsArchiv für Mikrobiologie, 1996